Suppr超能文献

异基因造血干细胞移植后肺部临床病理相关性:系列尸检研究。

Pulmonary Clinicopathological Correlation after Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series.

机构信息

Department of Medicine, Division of Pulmonary and Critical Care Medicine, Lahey Hospital and Medical Center, Burlington, Massachusetts.

Department of Medical Oncology, Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts.

出版信息

Biol Blood Marrow Transplant. 2017 Oct;23(10):1767-1772. doi: 10.1016/j.bbmt.2017.06.009. Epub 2017 Jun 28.

Abstract

Pulmonary complications are a significant cause of morbidity, mortality, and resource utilization after hematopoietic stem cell transplantation (HSCT). The objective of this study was to compare antemortem clinical suspicion of pulmonary complications and postmortem findings in a modern HSCT cohort. All patients who underwent allogeneic HSCT at our institution (n = 1854) between January 1, 2000 and June 30, 2010 were reviewed and patients who died of any cause greater than 1 year after HSCT and had an unrestricted autopsy available for analysis were included. Presence of pulmonary graft-versus-host disease (GVHD) was assessed by a pathologist blinded to the autopsy report, as previously described by Yousem (1995). A total of 35 (1.9%) patients had autopsies available for review. Airway disease, vascular disease, and interstitial disease were all clinically under-recognized compared with the pathological findings on autopsy. Varying degrees of pathological changes were detected, including 10 (28.6%) patients having bronchiolitis obliterans (BO) and 12 (34.3%) patients having pulmonary veno-occlusive disease (PVOD). Pulmonary manifestations of chronic GVHD, particularly BO and PVOD, were clinically under-recognized in our cohort. Our results suggest that PVOD, which has traditionally been considered a rare complication, may be clinically and histologically under-recognized.

摘要

肺并发症是造血干细胞移植(HSCT)后发病率、死亡率和资源利用的重要原因。本研究的目的是比较现代 HSCT 队列中肺并发症的生前临床疑似病例和死后发现。对 2000 年 1 月 1 日至 2010 年 6 月 30 日期间在我院接受异基因 HSCT 的所有患者(n=1854)进行了回顾性分析,纳入了 HSCT 后 1 年以上死于任何原因且有不受限制的尸检可供分析的患者。肺移植物抗宿主病(GVHD)的存在由一位对尸检报告不知情的病理学家按照 Yousem(1995 年)的方法进行评估。共有 35 例(1.9%)患者的尸检可供审查。与尸检的病理发现相比,气道疾病、血管疾病和间质性疾病在临床上都被低估了。检测到不同程度的病理变化,包括 10 例(28.6%)患者患有闭塞性细支气管炎(BO)和 12 例(34.3%)患者患有肺静脉闭塞性疾病(PVOD)。慢性 GVHD 的肺部表现,特别是 BO 和 PVOD,在我们的队列中被临床低估。我们的结果表明,PVOD 通常被认为是一种罕见的并发症,但在临床上和组织学上可能被低估。

相似文献

引用本文的文献

6
Noninfectious complications of hematopoietic cell transplantation.造血细胞移植的非感染性并发症。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):578-586. doi: 10.1182/hematology.2021000293.
10
Tumoral pulmonary hypertension.肿瘤性肺动脉高压。
Eur Respir Rev. 2019 Feb 6;28(151). doi: 10.1183/16000617.0065-2018. Print 2019 Mar 31.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验